Recruiting now—Ages 18 Years to 120 Years
Observational Study, for Quality Assessment, of Sarcoma in European and Latin American Multidisciplinary NETWORK
Sponsor: Grupo Espanol de Investigacion en Sarcomas · NCT04181970 on ClinicalTrials.gov ↗
Conditions studied
Soft-tissue SarcomaGastrointestinal Stromal TumorsBone Sarcoma
What it tests
- Quality assessmentother
Where it's running9 sites
9 international sites
- Opening soon
Alexander Fleming Sa
Buenos Aires, Argentina
- Matías Chacón, MD(contact)[email protected]
- Recruiting now
A C Camargo
São Paulo, Brazil
- Celso Mello, MD(contact)[email protected]
- Opening soon
Hospital San Vicente de Paúl
Heredia, Costa Rica
- Natalia Jimenez, MD(contact)[email protected]
- Recruiting now
Centre Leon Berard
Lyon, France
- Jean Y Blay, Prof MD(contact)[email protected]
- Recruiting now
Instituto Ortopedico Rizzoli
Bologna, Italy
- Alberto Righi, MD(contact)[email protected]
- Martina Piccini, MD(contact)[email protected]
- Recruiting now
Insituto Nazionale Di Tumore
Milan, Italy
- Paolo Casali, MD(contact)[email protected]
- Bruna David, MD(contact)[email protected]
- Recruiting now
Instituto Nacional de Cancerología
Mexico City, Mexico
- Jorge L Martínez Tlahuel, MD(contact)[email protected]
- Jorge Vikes, MD(contact)[email protected]
- Recruiting now
Instituo Nacional de enfermedades Neoplásicas
Surquillo, Peru
- Victor Castro Oliden, MD(contact)[email protected]
- Recruiting now
Fundación Jiménez Díaz
Madrid, Madrid, Spain 28040
- Javier MARTIN-BROTO, MD(contact)[email protected]
- Nadia Hindi Muñiz, MD(contact)[email protected]
See the official eligibility language
Shown exactly as written on ClinicalTrials.gov. Your oncologist is the right person to judge whether it fits your situation.
Inclusion Criteria: * Histological diagnosis of soft-tissue sarcoma, GIST or bone sarcoma (all subtypes) from January 2005 until Juny/September 2023. * ≥ 18 years * Available clinical and treatment information Exclusion Criteria: There is no exclusion criteria
Updated 2025-03-21 on ClinicalTrials.gov. Always confirm current details with the study team or your oncologist.